HCM Q2 2019 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$50M+0.4% YoY

Gross Profit

$12M24.8% margin

Operating Income

-$36M-71.9% margin

Net Income

-$25M-50.9% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

-4.1%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$495M

Total Liabilities

$122M

Stockholders' Equity

$348M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$50M	+0.4%
Gross Profit	$12M	$15M	-17.5%
Operating Income	-$36M	-$29M	-25.5%
Net Income	-$25M	-$21M	-21.6%